Perspectives

Conversations, research, ideas, and news at the interface of technology and biology.

New York Times

Lorem ipsum dolor sit amet on sectetur lorem ipsum um dolor sit amet on secteturhjhkhh dashk lorem ipsum jhkhh dashk lorem ipsum

New York Times

Lorem ipsum dolor sit amet on sectetur lorem ipsum um dolor sit amet on secteturhjhkhh dashk lorem ipsum jhkhh dashk lorem ipsum

New York Times

Lorem ipsum dolor sit amet on sectetur lorem ipsum um dolor sit amet on secteturhjhkhh dashk lorem ipsum jhkhh dashk lorem ipsum

MedCity News

Here’s a look at natural product drug discovery 2.0

Beyond Biotech

A podcast exploring tech-enabled bio innovation and its potential to change life as we know it.

Episode 
1
The future possible

Press

Forbes

These Venture Veterans Have Launched A $350 Million Fund Aimed At Digitizing Life Sciences

Newcomer

A New Dimension (w/Nan Li, Adam Goulburn, and Zavain Dar)

Fortune

Three venture investors weigh in on the future of biotech as they launch a new $350M fund

Wall Street Journal

New VC Firm Dimension Gets $350 Million as Healthcare Venture Fundraising Remains High

Endpoints

‘Siloing is just so outdated’: New $350M VC fund aims to digitize life sciences

STAT

Focused exclusively on life sciences, three top investors set out on their own

Timmerman Report

Dimension Debuts With 350M To Back Startups That Digitize Biology

BioPharma Dive

Three VCs launch Dimension, a new firm with plans to fuel biotech’s ‘digitization’

Fierce Biotech

Creating a new dimension: Biotech VC merging tech and life sciences unveils with $350M

BioSpace

As Tech Giants Fall, Tech-Focused VC Fund Rakes in $350M